Sweanor David
Faculty of Law University of Ottawa Centre for Health Law, Policy and Ethics, University of Ottawa. Honorary (Consultant) Assistant Professor, University of Nottingham, UK..
Can J Public Health. 2016 Mar 16;106(8):e464-6. doi: 10.17269/cjph.106.5389.
The development of policies on vaping in health care organizations (HCOs) needs to be based on a solid understanding of science and a recognition of individual rights. It should also be seen in the broader public health context of innovative alternative nicotine delivery systems playing a key role in ending the immense devastation of combustible cigarettes. Opposition to vaping based on inaccurate and incomplete information, or fear of unlikely and avoidable hypothetical unintended consequences, will invariably cause great harm to individuals, impede rather than assist the attainment of public health objectives, and unnecessarily prolong the epidemic of cigarette-caused diseases.
医疗保健机构（HCOs）中电子烟政策的制定需要基于对科学的扎实理解和对个人权利的认可。还应在更广泛的公共卫生背景下看待这一问题，即创新的替代尼古丁递送系统在终结可燃香烟造成的巨大破坏方面发挥着关键作用。基于不准确和不完整的信息或对不太可能且可避免的假设性意外后果的恐惧而反对电子烟，将不可避免地对个人造成极大伤害，阻碍而非有助于实现公共卫生目标，并不必要地延长由香烟导致的疾病的流行。
